Patent 7482022 was granted and assigned to Pfizer Limited on January, 2009 by the United States Patent and Trademark Office.
A palatable chewable tablet is described herein for oral administration of cetirizine dihydrochloride. The formulation is made more palatable by incorporating a combination of a grape flavoring agent with a vanilla flavoring agent.